Scientists scan brains to see why some drinkers respond differently to medication
NCT ID NCT02639273
Summary
This small, completed study aimed to understand how a medication called nalmefene affects the brain's response to alcohol cues and drinking behavior in heavy drinkers. It also tested whether a specific gene variation (OPRM1) changes how people respond to the medication. Thirteen healthy heavy drinkers received the medication or a placebo, had brain scans, and participated in controlled alcohol sessions to measure their reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.